Investors interested in Consumer Products - Staples stocks are likely familiar with Ahold NV (ADRNY) and Clorox (CLX) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highli ...

Core Viewpoint - Clorox has filed a lawsuit against Cognizant, alleging negligence in handling a cyberattack that resulted in significant financial damages due to a breach by the hacking group Scattered Spider in August 2023 [1][2][4]. Group 1: Cyberattack Details - The cyberattack was executed by Scattered Spider, which is known for tricking IT help desks into providing access credentials [1][6]. - Clorox claims that the hacker gained access by simply requesting passwords from Cognizant's support staff without any sophisticated techniques [2][3]. - The lawsuit includes transcripts of conversations where Cognizant staff reset passwords without verifying the hacker's identity [4]. Group 2: Financial Impact - The total damages from the cyberattack are estimated at $380 million, with approximately $50 million attributed to remedial costs and the remainder due to Clorox's inability to ship products to retailers [4]. - Clorox's operational recovery was further complicated by Cognizant's failures, such as not deactivating certain accounts and improperly restoring data [5].

Core Insights - Clorox Company (CLX) is leveraging its pricing strength to drive growth and manage cost pressures effectively [1][10] - The company employs a dual pricing strategy, balancing affordability for consumers with profitability [2][10] - Clorox has achieved gross margin expansion for ten consecutive quarters, supported by disciplined pricing and cost-saving initiatives [3][5] Pricing Strategy - Clorox utilizes advanced analytics to identify price inflection points and selectively adjusts prices on value-sensitive SKUs while enhancing promotional support for higher-margin products [2] - The company is focused on premium pricing for its core brands, emphasizing premiumization and consumer value [1][10] - Clorox does not anticipate broad-based price increases but is evaluating specific adjustments in categories driven by value and innovation [4] Operational Efficiency - The company has improved efficiency across manufacturing and logistics, contributing to margin growth [4] - Recent divestitures of lower-margin operations, such as the VMS and Argentina businesses, have further supported margin expansion [4] - Clorox's streamlined operating model aims to enhance overall efficiency [3] Financial Performance - Clorox projects an adjusted EPS of $6.95-$7.35 for fiscal 2025, indicating a year-over-year increase of 13-19% [5] - The Zacks Consensus Estimate for fiscal 2025 earnings implies a growth of 14.9%, while a decline of 8.1% is expected for fiscal 2026 [15] - Clorox shares have declined by 21.5% year-to-date, compared to a 4.4% decline in the industry [13] Competitive Landscape - Major competitors in pricing strength include Colgate-Palmolive, Procter & Gamble, and Church & Dwight [6] - Colgate has seen a 1.5% improvement in pricing, with expectations of 2.5% growth in 2025 [7] - Procter & Gamble's pricing strategy focuses on value-based pricing to maintain market share and reduce reliance on discounts [8] - Church & Dwight has gained market share in nine of its 14 major brands, demonstrating solid brand performance [9]

Group 1 - The Clorox Company will announce its fourth-quarter and fiscal year 2025 results on July 31, 2025 [1] - The announcement will include a press release and prepared management remarks available on the company's website [3] - A live Q&A audio webcast for analysts will be held with the Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet [3] Group 2 - Clorox is headquartered in Oakland, California, and has been in operation since 1913 [2] - The company integrates ESG into its business reporting and was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year in 2025 [2] - Clorox's trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, and Pine-Sol®, along with international brands such as Clorinda®, Chux®, and Poett® [2]

Core Insights - The article emphasizes the effectiveness of investing in dividend growth stocks and reinvesting dividends as a strategy for long-term wealth growth [1] Group 1: Investment Strategy - The individual investor has explored various investment styles over 25 years, concluding that dividend growth stocks are a reliable method for wealth accumulation [1] - The investor has experience with a diverse range of investment vehicles, including stocks, options, ETFs, treasury notes, and mutual funds [1] - The blog, HarvestingDividends.com, focuses on providing information about S&P Dividend Aristocrats and other dividend growth stocks [1]

Generative AI Application - Clorox 利用生成式 AI 进行实验，以获得新的研发想法和更深入的客户洞察 [1] - Clorox's experiments also delivered some misfires [1]

Core Viewpoint - The Clorox Company experienced significant stock performance during the pandemic, with demand for cleaning supplies surging, leading to a rise in stock price from approximately $150 at the beginning of 2020 [1] Group 1: Company Performance - The Clorox Company's stock price increased notably during the pandemic due to heightened demand for cleaning products [1] Group 2: Market Context - The pandemic era created a favorable environment for companies in the cleaning supplies sector, as consumer demand surged [1]

Core Insights - The Clorox Company's international expansion is essential for long-term success, especially as growth in domestic markets slows, with international sales currently accounting for nearly 16% of total revenues, indicating significant untapped potential abroad [1][10] - Clorox aims to enhance its international presence by focusing on high-growth emerging markets like Latin America and Asia, where rising middle-class populations and changing hygiene habits align with its product offerings [1][2] International Sales Performance - Clorox's international sales declined by 15% year over year in Q3 fiscal 2025, primarily due to the divestiture in Argentina; however, excluding this impact and a 3-point headwind from foreign exchange rates, organic sales grew by 2% [3][10] - The company anticipates organic sales growth of 15% in Q4 and 8.2% for fiscal 2025 in its international segment [3][10] Strategic Focus - To succeed internationally, Clorox must balance brand recognition with pricing power, invest in localized product innovation, and adapt to diverse regulatory environments, while also navigating currency fluctuations and supply chain complexities [2] - The company is implementing its Go Lean strategy to enhance product innovation and operational efficiency across key global markets [2][4] Competitive Landscape - As Clorox accelerates its international expansion, competitors like Procter & Gamble, Colgate-Palmolive, and Church & Dwight are also intensifying their efforts to maintain their global market positions [5] - Procter & Gamble's international markets contributed approximately 20% of its net sales in fiscal 2024, while Colgate operates in over 200 countries, focusing on high-growth emerging markets [6][7] Financial Performance and Valuation - Clorox shares have declined by 26.3% year to date, compared to the industry's decline of 1.8% [11] - The company trades at a forward price-to-earnings ratio of 17.80X, below the industry average of 20.37X [12] - The Zacks Consensus Estimate for Clorox's fiscal 2025 earnings implies a year-over-year growth of 14.9%, while fiscal 2026 shows a decline of 5.3% [13]

Company Overview - The Clorox Company (CLX) is experiencing significant activity in the options market, particularly with the Jan 16, 2026 $60.00 Call option showing high implied volatility, indicating potential for a major price movement [1][3] Implied Volatility Insights - Implied volatility reflects market expectations for future stock movement, suggesting that investors anticipate a significant change in Clorox's stock price, possibly due to an upcoming event [2][4] Analyst Sentiment - Clorox currently holds a Zacks Rank 3 (Hold) within the Consumer Products - Staples industry, which is positioned in the bottom 31% of the Zacks Industry Rank [3] - Over the past 60 days, four analysts have raised their earnings estimates for Clorox for the current quarter, while two have lowered theirs, resulting in a consensus estimate increase from $2.16 to $2.25 per share [3]

Core Insights - Innovation is central to The Clorox Company's strategy to compete against global giants and cost-effective private labels, focusing on consumer-centric improvements in performance, sensory appeal, and convenience [1][3] - Clorox's dual approach to innovation includes premiumization across categories and expanding price-pack architecture to cater to budget-conscious consumers, while maintaining disciplined promotional strategies [2][9] - The company is committed to investing in R&D and digital transformation to enhance innovation and supply chain responsiveness, viewing innovation as a key driver for long-term growth and margin expansion [3] Competitive Landscape - Key competitors in the consumer staples sector include Procter & Gamble, Colgate-Palmolive, and Church & Dwight, all of which employ various strategies to enhance their product offerings [4] - Procter & Gamble focuses on continuous improvement of popular brands with new features and budget options [5] - Colgate emphasizes value-driven innovation and sustainability, targeting both budget-conscious and environmentally aware consumers [6] - Church & Dwight is known for its value-focused innovation, offering affordable and functional products that compete directly with Clorox [7] Financial Performance - Clorox shares have decreased by 25.5% year-to-date, contrasting with the industry's growth of 2.2% [8] - The company trades at a forward price-to-earnings ratio of 18.0X, which is below the industry average of 20.23X [10] - The Zacks Consensus Estimate indicates a year-over-year earnings growth of 14.9% for 2025, followed by a decline of 5.4% in 2026, with estimates remaining unchanged over the past 30 days [11]